BioLife Solutions, Inc.
BLFS
$25.65
-$0.26-1.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 37.65% | 8.75% | -13.92% | -50.43% | -61.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 37.65% | 8.75% | -13.92% | -50.43% | -61.25% |
| Cost of Revenue | 114.14% | -17.56% | -48.93% | -84.13% | -89.82% |
| Gross Profit | 22.45% | 21.20% | 8.88% | -1.08% | -12.45% |
| SG&A Expenses | 6.49% | -9.55% | -19.13% | -34.42% | -34.70% |
| Depreciation & Amortization | 12.33% | -17.66% | -35.11% | -70.23% | -69.57% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.08% | -14.66% | -30.96% | -59.75% | -63.58% |
| Operating Income | 76.68% | 87.17% | 81.38% | 90.59% | 72.22% |
| Income Before Tax | -25.00% | 52.54% | 51.66% | 101.13% | 82.42% |
| Income Tax Expenses | 81.00% | -45.45% | -487.50% | -295.97% | 83.05% |
| Earnings from Continuing Operations | -25.82% | 53.29% | 52.36% | 101.43% | 82.42% |
| Earnings from Discontinued Operations | 117.38% | 91.52% | 77.00% | -111.87% | -541.53% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 92.63% | 83.86% | 70.32% | 53.44% | 10.06% |
| EBIT | 76.68% | 87.17% | 81.38% | 90.59% | 72.22% |
| EBITDA | 784.51% | 146.81% | 125.70% | 122.50% | 97.70% |
| EPS Basic | 93.40% | 84.29% | 71.38% | 55.89% | 13.74% |
| Normalized Basic EPS | 92.94% | 90.49% | 82.11% | 90.88% | 72.31% |
| EPS Diluted | 92.78% | 83.58% | 70.72% | 55.89% | 13.74% |
| Normalized Diluted EPS | 92.55% | 90.29% | 81.95% | 90.88% | 72.31% |
| Average Basic Shares Outstanding | 4.41% | 4.91% | 5.37% | 5.56% | 4.61% |
| Average Diluted Shares Outstanding | 5.18% | 5.69% | 6.16% | 5.56% | 4.61% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |